• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NHEJ抑制剂CYREN对S期和G2期DNA修复途径选择的调控

Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN.

作者信息

Arnoult Nausica, Correia Adriana, Ma Jiao, Merlo Anna, Garcia-Gomez Sara, Maric Marija, Tognetti Marco, Benner Christopher W, Boulton Simon J, Saghatelian Alan, Karlseder Jan

机构信息

The Salk Institute for Biological Studies, 10010 North Torrey Pines Rd., La Jolla, California 92037, USA.

Dsb Repair Metabolism Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.

出版信息

Nature. 2017 Sep 20;549(7673):548-552. doi: 10.1038/nature24023.

DOI:10.1038/nature24023
PMID:28959974
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5624508/
Abstract

Classical non-homologous end joining (cNHEJ) and homologous recombination compete for the repair of double-stranded DNA breaks during the cell cycle. Homologous recombination is inhibited during the G1 phase of the cell cycle, but both pathways are active in the S and G2 phases. However, it is unclear why cNHEJ does not always outcompete homologous recombination during the S and G2 phases. Here we show that CYREN (cell cycle regulator of NHEJ) is a cell-cycle-specific inhibitor of cNHEJ. Suppression of CYREN allows cNHEJ to occur at telomeres and intrachromosomal breaks during the S and G2 phases, and cells lacking CYREN accumulate chromosomal aberrations upon damage induction, specifically outside the G1 phase. CYREN acts by binding to the Ku70/80 heterodimer and preferentially inhibits cNHEJ at breaks with overhangs by protecting them. We therefore propose that CYREN is a direct cell-cycle-dependent inhibitor of cNHEJ that promotes error-free repair by homologous recombination during cell cycle phases when sister chromatids are present.

摘要

经典非同源末端连接(cNHEJ)和同源重组在细胞周期中竞争双链DNA断裂的修复。同源重组在细胞周期的G1期受到抑制,但这两种途径在S期和G2期均活跃。然而,尚不清楚为何在S期和G2期cNHEJ并不总是胜过同源重组。在此我们表明,CYREN(非同源末端连接的细胞周期调节因子)是cNHEJ的细胞周期特异性抑制剂。CYREN的抑制使得cNHEJ在S期和G2期能在端粒和染色体内断裂处发生,并且缺乏CYREN的细胞在损伤诱导后会积累染色体畸变,特别是在G1期之外。CYREN通过与Ku70/80异二聚体结合发挥作用,并通过保护有突出端的断裂优先抑制cNHEJ。因此,我们提出CYREN是cNHEJ直接的细胞周期依赖性抑制剂,在有姐妹染色单体存在的细胞周期阶段通过同源重组促进无差错修复。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/250768a67009/emss-73757-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/539814c77525/emss-73757-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/d7d93e7d3f7f/emss-73757-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/0540daa99521/emss-73757-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/8ecb25d9776f/emss-73757-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/7b9255e312d6/emss-73757-f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/9df37cb2428f/emss-73757-f010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/0a4f7280a4ca/emss-73757-f011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/049aea01e4eb/emss-73757-f012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/fd9af80fbfaf/emss-73757-f013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/999a855ccad4/emss-73757-f014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/05a0cf75381a/emss-73757-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/98c3829f67c5/emss-73757-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/5141c5d96dad/emss-73757-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/250768a67009/emss-73757-f004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/539814c77525/emss-73757-f005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/d7d93e7d3f7f/emss-73757-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/0540daa99521/emss-73757-f007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/8ecb25d9776f/emss-73757-f008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/7b9255e312d6/emss-73757-f009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/9df37cb2428f/emss-73757-f010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/0a4f7280a4ca/emss-73757-f011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/049aea01e4eb/emss-73757-f012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/fd9af80fbfaf/emss-73757-f013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/999a855ccad4/emss-73757-f014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/05a0cf75381a/emss-73757-f001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/98c3829f67c5/emss-73757-f002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/5141c5d96dad/emss-73757-f003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e60/5624508/250768a67009/emss-73757-f004.jpg

相似文献

1
Regulation of DNA repair pathway choice in S and G2 phases by the NHEJ inhibitor CYREN.NHEJ抑制剂CYREN对S期和G2期DNA修复途径选择的调控
Nature. 2017 Sep 20;549(7673):548-552. doi: 10.1038/nature24023.
2
Analysis of chromatid-break-repair detects a homologous recombination to non-homologous end-joining switch with increasing load of DNA double-strand breaks.分析着丝粒断裂修复检测到同源重组向非同源末端连接的转换,这种转换随着 DNA 双链断裂负荷的增加而增加。
Mutat Res Genet Toxicol Environ Mutagen. 2021 Jul;867:503372. doi: 10.1016/j.mrgentox.2021.503372. Epub 2021 Jun 12.
3
[Smart choice between two DNA double-strand break repair mechanisms].[两种DNA双链断裂修复机制间的明智选择]
Igaku Butsuri. 2014;34(2):57-64.
4
CDK-mediated Yku80 Phosphorylation Regulates the Balance Between Non-homologous End Joining (NHEJ) and Homologous Directed Recombination (HDR).CDK 介导的 Yku80 磷酸化调节非同源末端连接(NHEJ)和同源定向重组(HDR)之间的平衡。
J Mol Biol. 2020 Dec 4;432(24):166715. doi: 10.1016/j.jmb.2020.11.014. Epub 2020 Nov 17.
5
A Stochastic Model of DNA Double-Strand Breaks Repair Throughout the Cell Cycle.细胞周期中 DNA 双链断裂修复的随机模型。
Bull Math Biol. 2020 Jan 14;82(1):11. doi: 10.1007/s11538-019-00692-z.
6
The anaphase promoting complex promotes NHEJ repair through stabilizing Ku80 at DNA damage sites.后期促进复合物通过稳定 DNA 损伤部位的 Ku80 促进 NHEJ 修复。
Cell Cycle. 2018;17(9):1138-1145. doi: 10.1080/15384101.2018.1464836. Epub 2018 Jul 18.
7
DNA end resection is needed for the repair of complex lesions in G1-phase human cells.在G1期人类细胞中修复复杂损伤需要DNA末端切除。
Cell Cycle. 2014;13(16):2509-16. doi: 10.4161/15384101.2015.941743.
8
Ku70 suppresses alternative end joining in G1-arrested progenitor B cells.Ku70 抑制 G1 期阻滞祖 B 细胞中的非同源末端连接。
Proc Natl Acad Sci U S A. 2021 May 25;118(21). doi: 10.1073/pnas.2103630118.
9
Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.细胞周期依赖性磷酸化调节 RECQL4 途径选择和 DNA 双链断裂修复中的泛素化。
Nat Commun. 2017 Dec 11;8(1):2039. doi: 10.1038/s41467-017-02146-3.
10
MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining.MRI 是经典非同源末端连接过程中的 DNA 损伤反应接头。
Mol Cell. 2018 Jul 19;71(2):332-342.e8. doi: 10.1016/j.molcel.2018.06.018. Epub 2018 Jul 12.

引用本文的文献

1
Chromatin-associated circRNA ciCRLF3(2) regulates cell differentiation blockage via activating non-homologous end joining-based DNA repair.染色质相关环状RNA ciCRLF3(2)通过激活基于非同源末端连接的DNA修复来调节细胞分化阻滞。
Cell Death Differ. 2025 Sep 4. doi: 10.1038/s41418-025-01574-9.
2
Epigenetic Dysregulation in Cancer: Implications for Gene Expression and DNA Repair-Associated Pathways.癌症中的表观遗传失调:对基因表达和DNA修复相关通路的影响。
Int J Mol Sci. 2025 Jul 7;26(13):6531. doi: 10.3390/ijms26136531.
3
Distinct functions of PAXX and MRI during chromosomal end joining.

本文引用的文献

1
The Ku-binding motif is a conserved module for recruitment and stimulation of non-homologous end-joining proteins.Ku结合基序是用于募集和刺激非同源末端连接蛋白的保守模块。
Nat Commun. 2016 Apr 11;7:11242. doi: 10.1038/ncomms11242.
2
A human short open reading frame (sORF)-encoded polypeptide that stimulates DNA end joining.一种人类短开放阅读框(sORF)编码的多肽,可刺激 DNA 末端连接。
J Biol Chem. 2014 Apr 18;289(16):10950-10957. doi: 10.1074/jbc.C113.533968. Epub 2014 Mar 7.
3
Rapid induction of alternative lengthening of telomeres by depletion of the histone chaperone ASF1.
PAXX和MRI在染色体末端连接过程中的不同功能。
iScience. 2025 May 22;28(6):112722. doi: 10.1016/j.isci.2025.112722. eCollection 2025 Jun 20.
4
Nuclear VPS35 attenuates NHEJ repair by sequestering Ku protein.细胞核内的VPS35通过隔离Ku蛋白来减弱非同源末端连接修复。
Mol Med. 2025 Jun 9;31(1):222. doi: 10.1186/s10020-025-01288-1.
5
TOX High-Mobility Group Box Family Member 4 promotes DNA double-strand break repair via nonhomologous end joining.TOX高迁移率族盒蛋白家族成员4通过非同源末端连接促进DNA双链断裂修复。
J Biol Chem. 2025 May 4;301(6):110174. doi: 10.1016/j.jbc.2025.110174.
6
Eukaryotic Microproteins.真核生物微小蛋白
Annu Rev Biochem. 2025 Jun;94(1):1-28. doi: 10.1146/annurev-biochem-080124-012840. Epub 2025 Apr 17.
7
A large-scale sORF screen identifies putative microproteins involved in cancer cell fitness.一项大规模的短开放阅读框筛选鉴定出了与癌细胞适应性相关的潜在微蛋白。
iScience. 2025 Jan 23;28(3):111884. doi: 10.1016/j.isci.2025.111884. eCollection 2025 Mar 21.
8
Genome-wide CRISPR activation screen identifies ARL11 as a sensitivity determinant of PARP inhibitor therapy.全基因组CRISPR激活筛选确定ARL11为PARP抑制剂治疗的敏感性决定因素。
Cancer Gene Ther. 2025 May;32(5):521-537. doi: 10.1038/s41417-025-00893-w. Epub 2025 Mar 23.
9
Homeodomain protein PRRX1 anchors the Ku heterodimers at DNA double-strand breaks to promote nonhomologous end-joining.同源结构域蛋白PRRX1将Ku异源二聚体锚定在DNA双链断裂处,以促进非同源末端连接。
Nucleic Acids Res. 2025 Mar 20;53(6). doi: 10.1093/nar/gkaf200.
10
Investigating synthetic lethality and PARP inhibitor resistance in pancreatic cancer through enantiomer differential activity.通过对映体差异活性研究胰腺癌中的合成致死性和PARP抑制剂耐药性。
Cell Death Discov. 2025 Mar 16;11(1):106. doi: 10.1038/s41420-025-02382-3.
通过耗尽组蛋白伴侣 ASF1 快速诱导端粒的替代性延长。
Nat Struct Mol Biol. 2014 Feb;21(2):167-74. doi: 10.1038/nsmb.2754. Epub 2014 Jan 12.
4
Double-strand break repair: 53BP1 comes into focus.双链断裂修复:53BP1 成为焦点。
Nat Rev Mol Cell Biol. 2014 Jan;15(1):7-18. doi: 10.1038/nrm3719. Epub 2013 Dec 11.
5
Super-resolution fluorescence imaging of telomeres reveals TRF2-dependent T-loop formation.端粒的超分辨率荧光成像显示 TRF2 依赖性 T 环形成。
Cell. 2013 Oct 10;155(2):345-356. doi: 10.1016/j.cell.2013.09.048.
6
A two-step mechanism for TRF2-mediated chromosome-end protection.TRF2 介导的染色体末端保护的两步机制。
Nature. 2013 Feb 28;494(7438):502-5. doi: 10.1038/nature11873. Epub 2013 Feb 6.
7
A cell cycle-dependent regulatory circuit composed of 53BP1-RIF1 and BRCA1-CtIP controls DNA repair pathway choice.一个由 53BP1-RIF1 和 BRCA1-CtIP 组成的细胞周期依赖性调控回路控制 DNA 修复途径的选择。
Mol Cell. 2013 Mar 7;49(5):872-83. doi: 10.1016/j.molcel.2013.01.001. Epub 2013 Jan 17.
8
53BP1 regulates DSB repair using Rif1 to control 5' end resection.53BP1 通过 Rif1 控制 5' 端切除来调节 DSB 修复。
Science. 2013 Feb 8;339(6120):700-4. doi: 10.1126/science.1231573. Epub 2013 Jan 10.
9
Multiplex genome engineering using CRISPR/Cas systems.利用 CRISPR/Cas 系统进行多重基因组工程。
Science. 2013 Feb 15;339(6121):819-23. doi: 10.1126/science.1231143. Epub 2013 Jan 3.
10
Playing the end game: DNA double-strand break repair pathway choice.玩终局游戏:DNA 双链断裂修复途径的选择。
Mol Cell. 2012 Aug 24;47(4):497-510. doi: 10.1016/j.molcel.2012.07.029.